Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Jan;24(1):20-5.

"Xenogeneic resistance" to rat bone marrow transplantation. III. Maturation age, and abrogation with cyclophosphamide, Corynebacterium parvum and fractionated irradiation

J M Rauchwerger, M T Gallagher, H J Monié, J J Trentin
  • PMID: 773442

"Xenogeneic resistance" to rat bone marrow transplantation. III. Maturation age, and abrogation with cyclophosphamide, Corynebacterium parvum and fractionated irradiation

J M Rauchwerger et al. Biomedicine. 1976 Jan.

Abstract

Lethally irradiated C57 Bl/6 mice and (C57 X A) F1 hybrids fail to accept doses of rat bone marrow cells (5 X 10(6)) which give confluent splenic repopulation in "non-resistant" strains of mice. This phenomenon has been termed "xenogeneic resistance" (XR). XR in (C57 X A) F1 mice can be overridden by a very large inoculum of rat bone marrow (26 X 10(6) cells). XR is not manifest in mice of a resistant strain at ages of 18 days or younger, but is manifest at ages of 22 days and older. XR can be abrogated by agents as varied as: 1) cyclophosphamide, which abrogates XR in a dose dependent manner when given 1 hr prior to lethal irradiation and bone marrow transplantation 2) C. parvum, which abrogates resistance when given 7 days prior to lethal irradiation and bone marrow transplantation, and 3) Fractionated irradiation, which, while capable of abrogating XR, is much less potent than either cyclophosphamide or C. parvum.

PubMed Disclaimer

MeSH terms